These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

651 related articles for article (PubMed ID: 20237805)

  • 21. World Workshop on Oral Medicine VI: a systematic review of medication-induced salivary gland dysfunction: prevalence, diagnosis, and treatment.
    Villa A; Wolff A; Aframian D; Vissink A; Ekström J; Proctor G; McGowan R; Narayana N; Aliko A; Sia YW; Joshi RK; Jensen SB; Kerr AR; Dawes C; Pedersen AM
    Clin Oral Investig; 2015 Sep; 19(7):1563-80. PubMed ID: 25994331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salivary gland hypofunction in elderly patients attending a xerostomia clinic.
    Longman LP; Higham SM; Rai K; Edgar WM; Field EA
    Gerodontology; 1995 Dec; 12(12):67-72. PubMed ID: 9084292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using technology to decrease xerostomia for head and neck cancer patients treated with radiation therapy.
    Amosson CM; Teh BS; Mai WY; Woo SY; Chiu JK; Donovan DT; Parke R; Carpenter LS; Lu HH; Grant WH; Butler EB
    Semin Oncol; 2002 Dec; 29(6 Suppl 19):71-9. PubMed ID: 12577249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel dose constraint to reduce xerostomia in head-and-neck cancer patients treated with intensity-modulated radiotherapy.
    Strigari L; Benassi M; Arcangeli G; Bruzzaniti V; Giovinazzo G; Marucci L
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):269-76. PubMed ID: 20100642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MASCC/ISOO Clinical Practice Statement: Management of salivary gland hypofunction and xerostomia in cancer patients.
    Hong C; Jensen SB; Vissink A; Bonomo P; Santos-Silva AR; Gueiros LA; Epstein JB; Elad S
    Support Care Cancer; 2024 Jul; 32(8):548. PubMed ID: 39048728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Xerostomia. Part I: Relationship to other oral symptoms and salivary gland hypofunction.
    Sreebny LM; Valdini A
    Oral Surg Oral Med Oral Pathol; 1988 Oct; 66(4):451-8. PubMed ID: 3186220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Quantitative and qualitative investigations of salivary gland function in dependence on irradiation dose and volume for reduction of xerostomia in patients with head-and-neck cancer].
    Kuhnt T; Jirsak N; Müller AC; Pelz T; Gernhardt C; Schaller HG; Janich M; Gerlach R; Dunst J
    Strahlenther Onkol; 2005 Aug; 181(8):520-8. PubMed ID: 16044220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management.
    Chambers MS; Garden AS; Kies MS; Martin JW
    Head Neck; 2004 Sep; 26(9):796-807. PubMed ID: 15350026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness landscape analysis of treatments addressing xerostomia in patients receiving head and neck radiation therapy.
    Sasportas LS; Hosford DN; Sodini MA; Waters DJ; Zambricki EA; Barral JK; Graves EE; Brinton TJ; Yock PG; Le QT; Sirjani D
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Jul; 116(1):e37-51. PubMed ID: 23643579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of minor salivary glands in developing patient-rated xerostomia and sticky saliva during day and night.
    Beetz I; Schilstra C; Visink A; van der Schaaf A; Bijl HP; van der Laan BF; Steenbakkers RJ; Langendijk JA
    Radiother Oncol; 2013 Nov; 109(2):311-6. PubMed ID: 23953752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic Phenotypes Underlying Radiation-Induced Salivary Gland Dysfunction.
    Gunning JA; Limesand KH
    J Dent Res; 2024 Jul; 103(8):778-786. PubMed ID: 38808518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing.
    Rosenthal DI; Chambers MS; Weber RS; Eisbruch A
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):25-8. PubMed ID: 15726519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of submandibular salivary gland transfer in preventing xerostomia in the chemoradiotherapy patient.
    Al-Qahtani K; Hier MP; Sultanum K; Black MJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jun; 101(6):753-6. PubMed ID: 16731395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of salivary hypofunction during and after radiotherapy.
    Shiboski CH; Hodgson TA; Ship JA; Schiødt M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103 Suppl():S66.e1-19. PubMed ID: 17379158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and Efficacy of Mesenchymal Stem Cells for Radiation-Induced Xerostomia: A Randomized, Placebo-Controlled Phase 1/2 Trial (MESRIX).
    Grønhøj C; Jensen DH; Vester-Glowinski P; Jensen SB; Bardow A; Oliveri RS; Fog LM; Specht L; Thomsen C; Darkner S; Jensen M; Müller V; Kiss K; Agander T; Andersen E; Fischer-Nielsen A; von Buchwald C
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):581-592. PubMed ID: 29678523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term oral effects in patients treated with radiochemotherapy for head and neck cancer.
    Deboni AL; Giordani AJ; Lopes NN; Dias RS; Segreto RA; Jensen SB; Segreto HR
    Support Care Cancer; 2012 Nov; 20(11):2903-11. PubMed ID: 22410861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.
    Vergeer MR; Doornaert PA; Rietveld DH; Leemans CR; Slotman BJ; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):1-8. PubMed ID: 19111400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Photobiomodulation Therapy for Cancer Treatment-Related Salivary Gland Dysfunction: A Systematic Review.
    Heiskanen V; Zadik Y; Elad S
    Photobiomodul Photomed Laser Surg; 2020 Jun; 38(6):340-347. PubMed ID: 32109187
    [No Abstract]   [Full Text] [Related]  

  • 39. Impact of submandibular gland excision on salivary gland function in head and neck cancer patients.
    Jaguar GC; Lima EN; Kowalski LP; Pellizon AC; Carvalho AL; Alves FA
    Oral Oncol; 2010 May; 46(5):349-54. PubMed ID: 20227906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies.
    Nieuw Amerongen AV; Veerman EC
    Support Care Cancer; 2003 Apr; 11(4):226-31. PubMed ID: 12673460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.